Search clinical trials for: unresectable hepatocelluar carcinoma

Total 31079 results

Gunma University

Completed

Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer

Carcinoma, Non-Small-Cell Lung
University of Aarhus

Unknown

MRI in Staging Ovarian Cancer Using MRI Contrast Agent

Ovarian Cancer
University of Glasgow
NHS Greater Glasgow and Clyde; Glasgow Western Infirmary

Unknown

A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base

Basal Cell Carcinoma

United Kingdom
Oncology Specialties, Alabama

Terminated

Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma

Metastatic Breast Cancer

United States
University Hospital, Geneva

Unknown

Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter

Pancreatic Neoplasms | Cholangiocarcinoma | Pancreatitis

Argentina
Women and Infants Hospital of Rhode Island
Millennium Pharmaceuticals, Inc.

Terminated

Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer

Cervical Cancer

United States
Grupo de Estudio de Infecciones en Transplantados
Merck Sharp & Dohme LLC

Unknown

Prophylaxis With Caspofungin in High-Risk Liver Transplantation

Liver Transplantation | Fungal Infection

Spain
National Taiwan University Hospital

Completed

Prognostic Significance of Fine-Needle Aspiration Cytology Features in Papillary Thyroid Carcinoma

Thyroid Neoplasms

Taiwan
Rambam Health Care Campus

Unknown

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Venous Thromboembolism | Non-Small Cell Lung Carcinoma

Israel
Grupo de Investigacao do Cancro Digestivo

Unknown

XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer

Colorectal Carcinoma

Portugal
Swedish Medical Center
Sanofi-Synthelabo

Terminated

Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer

Small Cell Lung Cancer

United States
Arpida AG

Completed

Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

Skin Diseases, Bacterial

United States
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma

Hepatitis B | Carcinoma, Hepatocellular | Polymorphism, Genetic

Taiwan
pSiVida Limited
pSiOncology Private Limited

Unknown

Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma

Liver Cancer

Singapore
LEO Pharma

Terminated

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

Liver Neoplasms

Spain, Canada, France, Italy, United Kingdom
Pharmacyclics LLC.

Completed

Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer

Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms

United States
Lab Discoveries Ltd.

Unknown

Blood Test for Ovarian Cancer Associated Antibodies (CAAb)

Ovarian Cancer

Israel
Pacira Pharmaceuticals, Inc

Completed

DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor

Meningeal Neoplasms

United States, Canada
Oncology Institute of Southern Switzerland

Completed

OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation

Differentiated Thyroid Carcinoma
YM BioSciences

Terminated

DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer

Breast Cancer | Metastases

United Kingdom
LEO Pharma

Terminated

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

Liver Neoplasms

Canada, France, Italy, Spain, United Kingdom
Sheba Medical Center

Unknown

Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva

Squamous Cell Carcinoma

Israel
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Unknown

Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients (Estimabl)

Thyroid Cancer

France
Hadassah Medical Organization

Unknown

Computer Assisted Early Detection of Liver Metastases From fMRI Maps

Metastatic Colorectal Cancer

Israel
Heidelberg University
Dietmar Hopp Stiftung; Prof. Wolfgang Stremmel

Completed

Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis

Ulcerative Colitis

Germany
Women and Infants Hospital of Rhode Island

Terminated

Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.

Breast Cancer | Ovarian Cancer

United States
ProteoSys AG
Charite University, Berlin, Germany; Medical University Innsbruck; University... and other collaborators

Unknown

Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma

Benign Prostatic Hyperplasia | Prostate Cancer | Prostatic Intraepithelial Neoplasia
National Cancer Center, Korea

Unknown

VATS Lobectomy for Clinical Stage IB or II Lung Cancer

Carcinoma, Non-Small-Cell Lung | Thoracic Surgery, Video-Assisted

Korea, Republic of
Eli Lilly and Company

Completed

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Depression, Bipolar

United States, Puerto Rico
Eli Lilly and Company

Completed

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

Gastrointestinal Neoplasms

Korea, Republic of
Eli Lilly and Company

Completed

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

Carcinoma, Small Cell

United States
Eli Lilly and Company

Completed

A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma

Advanced Gastric Carcinoma

Italy
Eli Lilly and Company

Completed

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung

China, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
Eli Lilly and Company

Completed

Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
Memorial Sloan Kettering Cancer Center

Completed

Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Eli Lilly and Company

Completed

Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.

Non-Small-Cell Lung Carcinoma

Argentina, Brazil, Chile, Mexico
Eli Lilly and Company

Completed

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

Adenocarcinoma

Canada
Eli Lilly and Company
Aventis Pharmaceuticals

Completed

A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Italy
Eli Lilly and Company

Completed

Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
Celgene Corporation
Prologue Research International

Completed

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Celgene Corporation

Completed

Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)

Prostate Cancer

United States
National Taiwan University Hospital

Unknown

The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients

Ovarian Cancer

Taiwan
Corixa Corporation

Unknown

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Amsterdam UMC, location VUmc
GlaxoSmithKline; The Netherlands Cancer Institute

Completed

Randomized Trial of Fluticasone in Bronchial Premalignancy

Bronchogenic Carcinoma

Netherlands
National Institute of Cancerología
National Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.

Completed

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

Cervical Cancer

Mexico
AGO Study Group

Completed

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer
AGO Study Group

Completed

Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
Pfizer

Completed

PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients

Carcinoma, Non-Small Cell Lung

United States, Canada
National Institute of Cancerología
National Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.

Terminated

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

Locally Advanced Breast Cancer

Mexico

Search clinical trials for: unresectable hepatocelluar carcinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations